
Edwards Lifesciences Corporation EW
€ 68.61
-3.63%
Geschäftsbericht 2025
hinzugefügt 25.02.2026
Edwards Lifesciences Corporation Gesamtverbindlichkeiten 2011-2026 | EW
Gesamtverbindlichkeiten Jährlich Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.36 B | 2.99 B | 2.64 B | 2.49 B | 2.67 B | 2.66 B | 2.34 B | 2.18 B | 2.74 B | 1.89 B | 1.56 B | 1.33 B | 1.17 B | 742 M | 643 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.36 B | 643 M | 2.09 B |
Gesamtverbindlichkeiten Vierteljährlich Edwards Lifesciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.07 B | 2.88 B | 2.83 B | 2.99 B | 3.36 B | 2.59 B | 2.55 B | 2.64 B | 2.64 B | 2.56 B | 2.59 B | 2.49 B | 2.42 B | - | 2.58 B | 2.67 B | 2.62 B | - | - | 2.66 B | 2.66 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.36 B | 2.42 B | 2.71 B |
Gesamtverbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Viemed Healthcare
VMD
|
55.6 M | $ 9.21 | -0.11 % | $ 358 M | ||
|
Varex Imaging Corporation
VREX
|
621 M | $ 10.82 | 0.37 % | $ 448 M | ||
|
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | ||
|
Abbott Laboratories
ABT
|
36.6 B | $ 105.12 | 0.53 % | $ 183 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Vivos Therapeutics
VVOS
|
7.33 M | $ 1.12 | -5.88 % | $ 5.62 M | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | ||
|
Align Technology
ALGN
|
2.36 B | $ 165.94 | -6.42 % | $ 12.4 B | ||
|
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
Beyond Air
XAIR
|
15.7 M | $ 0.68 | -1.74 % | $ 46 M | ||
|
Accuray Incorporated
ARAY
|
389 M | $ 0.39 | 4.43 % | $ 40.1 M | ||
|
Alphatec Holdings
ATEC
|
126 M | $ 11.05 | -4.12 % | $ 1.66 B | ||
|
Xtant Medical Holdings
XTNT
|
50.9 M | $ 0.57 | 0.5 % | $ 76.2 M | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
Zimmer Biomet Holdings
ZBH
|
8.89 B | $ 88.45 | -0.79 % | $ 18 B | ||
|
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
Bruker Corporation
BRKR
|
3.99 B | $ 34.22 | -3.17 % | $ 5.1 K | ||
|
Boston Scientific Corporation
BSX
|
16.7 B | $ 69.21 | -1.37 % | $ 102 B | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
CONMED Corporation
CNMD
|
1.29 B | $ 35.63 | -2.76 % | $ 1.11 B | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
3 M | - | - | $ 1.08 M | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
36.3 M | $ 0.59 | -1.68 % | $ 32.1 M | ||
|
Aethlon Medical
AEMD
|
2.24 M | $ 2.22 | -2.2 % | $ 3.47 M | ||
|
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
2.79 B | $ 11.15 | -2.28 % | $ 1.51 B | ||
|
IRIDEX Corporation
IRIX
|
24.9 M | $ 0.97 | -28.14 % | $ 15.6 M | ||
|
Penumbra
PEN
|
399 M | $ 335.13 | -0.38 % | $ 13 B | ||
|
OrthoPediatrics Corp.
KIDS
|
162 M | $ 15.76 | -3.64 % | $ 370 M | ||
|
LivaNova PLC
LIVN
|
1.41 B | $ 61.5 | -3.38 % | $ 3.35 B | ||
|
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
7.58 M | - | 10.0 % | $ 610 K | ||
|
Myomo
MYO
|
27.2 M | $ 0.68 | 0.43 % | $ 28.5 M | ||
|
Inspire Medical Systems
INSP
|
126 M | $ 49.39 | -2.1 % | $ 1.45 B | ||
|
Pulmonx Corporation
LUNG
|
75.2 M | $ 1.17 | -5.65 % | $ 47.6 M |